# reload+after+2024-01-22 14:46:32.951274
address1§712 Vista Boulevard
address2§Suite 305
city§Waconia
state§MN
zip§55387
country§United States
phone§952 479 1196
website§https://www.panbela.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, develops disruptive therapeutics for the treatment of patients with cancer. The company's lead product candidates are Ivospemin (SBP-101), which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; FlynpoviTM, a combination of eflornithine (CPP-1X) and sulindac; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase. It has a research agreement with the Johns Hopkins University School of Medicine for the development of ivospemin (SBP-101). The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
fullTimeEmployees§6
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.', 'age': 55, 'title': 'CEO, President & Director', 'yearBorn': 1968, 'fiscalYear': 2023, 'totalPay': 527000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susan  Horvath', 'age': 64, 'title': 'VP of Finance, CFO, Secretary & Treasurer', 'yearBorn': 1959, 'fiscalYear': 2023, 'totalPay': 333000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Tammy  Groene', 'title': 'Vice President of Operations', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Elizabeth  Bruckheimer Ph.D.', 'title': 'VP & Chief Scientific Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.923
currency§USD
dateShortInterest§1702598400
forwardEps§-3.13
exchange§NCM
quoteType§EQUITY
shortName§Panbela Therapeutics, Inc.
longName§Panbela Therapeutics, Inc.
firstTradeDateEpochUtc§1483453800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§65af0cc9-415e-3d25-afda-b689cbccb358
gmtOffSetMilliseconds§-18000000
targetHighPrice§25.0
targetLowPrice§16.0
targetMeanPrice§20.5
targetMedianPrice§20.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§0.119
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
